Agarose gel electrophoresis results of PCR products. gan Shuang Li (146392)

Pynciau:

The degradation of PNP by <i>P</i>. <i>putida</i> DLL-E4, DLL-Δ<i>crc</i>, DLL-Δ<i>crc</i>Y, and DLL-Δ<i>crcZ</i>. gan Shuang Li (146392)

Pynciau:

The growth of <i>P</i>. <i>putida</i> DLL-E4, DLL-Δ<i>crc</i>, DLL-Δ<i>crcY</i>, and DLL-Δ<i>crcZ</i> on LB medium. gan Shuang Li (146392)

Pynciau:

Aggregated results for reported benefits and harms, stratified by leaflets and booklets. gan Maren Dreier (628959)

“...<p>The figure indicates whether a leaflet contains <u>any</u> information on the benefits of CRC screening a) in general or specifically for b) colonoscopy or c) the FOBT, and whether it contains any information on the d) general and e) specific harms of colonoscopy. To be rated positive for harms, it was not sufficient if the only information about possible harms referred to pain, stating incorrectly that there is no pain involved....”

Trend of total annual payments from pharmaceutical companies to breast cancer specialists in Japan, 2016–2019. gan Yudai Kaneda (12337733)

Pynciau:

Overview of pharmaceutical payments to breast cancer specialists in Japan, 2016–2019. gan Yudai Kaneda (12337733)

Pynciau:

S1 Data - gan Yudai Kaneda (12337733)

Pynciau:

Total payments and annual changes for top 10 pharmaceutical companies to breast cancer specialists in Japan, 2016–2019. gan Yudai Kaneda (12337733)

Pynciau:

New drug introductions and changes in pharmaceutical company payments to breast cancer specialists in Japan, 2016–2019. gan Yudai Kaneda (12337733)

Pynciau:

Payment data to breast cancer specialists from pharmaceutical companies during the study period. gan Yudai Kaneda (12337733)

Pynciau:

Trends of pharmaceutical payment breakdowns across four years. gan Yudai Kaneda (12337733)

Pynciau:

OP50-seeded plates retained most of the G₁ embryos after a wash with M9 buffer to remove P₀ adults. gan Nikita S. Jhaveri (21175316)

Robustness check: T-tests of positive sentiment between those who did and did not report assault experience, removing “rape” and “raped” (Bing lexicon). gan MacKenzie Caputo (18813517)

Recording Harms in Behavioural change Intervention Trials (RHABIT) Project Protocol gan Diana Papaioannou (2758093)

“...It consists of 4 work packages (WP): WP1 Scoping review of literature to identify definitions, typologies, instruments, and suggested principles for recording harms in behavioural change intervention (BCI) trials; WP2 Qualitative interviews with clinical trials unit (CTU) and NIHR investigators involved in designing and delivering BCI trials; WP3 Workshop(s) to review guidance for recording harms in BCI trials; and WP4 Suggested principles and considerations for harms recording in BCI trials....”

Surface Topography-Adaptive Robotic Superstructures for Biofilm Removal and Pathogen Detection on Human Teeth gan Min Jun Oh (1396507)

Pynciau:

Surface Topography-Adaptive Robotic Superstructures for Biofilm Removal and Pathogen Detection on Human Teeth gan Min Jun Oh (1396507)

Pynciau:

Surface Topography-Adaptive Robotic Superstructures for Biofilm Removal and Pathogen Detection on Human Teeth gan Min Jun Oh (1396507)

Pynciau:

Surface Topography-Adaptive Robotic Superstructures for Biofilm Removal and Pathogen Detection on Human Teeth gan Min Jun Oh (1396507)

Pynciau:

Surface Topography-Adaptive Robotic Superstructures for Biofilm Removal and Pathogen Detection on Human Teeth gan Min Jun Oh (1396507)

Pynciau:

Relative expression (plate normalized) of <i>Mps1</i> in ovaries is determined strictly by genotype and the dose of <i>A15</i> alleles, indicating a strict zygotic effect on gene e... gan Danny E. Miller (7832204)

Pynciau: